abstract |
The disclosure provides, in part, compounds that have allosteric effector properties against hepatitis B virus Cp. Also provided herein is a method of treating a viral infection, such as hepatitis B, comprising administering the disclosed compound to a patient in need of treatment of the viral infection. For example, the disclosure also provides, in part, a compound selected from the group consisting of the compounds described in the Examples below, and pharmaceutically acceptable salts thereof. In one embodiment, the present disclosure provides a pharmaceutically acceptable composition comprising a disclosed compound and a pharmaceutically acceptable additive. |